Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-003184
Accepted
2024-10-16 00:15:04
Documents
1
Effectiveness Date
2024-10-15
Registration Form
POS AM
Reference AccNo

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 601
  Complete submission text file 9999999995-24-003184.txt   1766
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-322-1602
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0331
Type: EFFECT | Act: 33 | File No.: 333-280536 | Film No.: 241373156
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)